section name header

Pearl

Brugada Syndrome criteria

Brugada Syndrome is an autosomal dominant transmitted condition with male predominance (8:1) that results in high risk of sudden cardiac death due to ventricular tachyarrhythmia.

Facts about Brugada Syndrome:

Electrocardiographic findings:

Additional Criteria

Type 1 EKG morphology example:

Type 2 EKG morphology example:

The EKG findings of Brugada syndrome are often dynamic and may be concealed until unmasked by either a drug or other medical condition such as:

Treatment:

The only proven effective therapy for Brugada syndrome is placement of an Implanted Cardiac Defibrillator (ICD). Patients with Type 1, 2, or 3 findings on EKG without any of the additional “Clinical Criteria” require further evaluation to determine whether or not they have Brugada Syndrome and require ICD placement.

References

Alings M, Wilde A. “Brugada” syndrome: clinical data and suggested pathophysiological mechanism. Circulation. 1999 Feb 9;99(5):666-73.

Antzelevitch C, et al. Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation. 2005 Feb 8;111(5):659-70.

Brugada J, et al. Determinants of sudden cardiac death in individuals with the electrocardiographic pattern of Brugada syndrome and no previous cardiac arrest. Circulation. 2003 Dec 23;108(25):3092-6.

Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol. 1992 Nov 15;20(6):1391-6.

Wilde AA, et al. Proposed Diagnostic Criteria for the Brugada syndrome. Circulation. 2002 Nov 5;106(19)2514-9.


[Outline]